DIGITALIZATION OF PERSONALISED HEALTH RISK MANAGEMENT
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age25-65
SponsorSlovak Academy of Sciences
About this trial
The principal objective of the project is:
* to bring together academic and business research organisations in a joint partnership integrating technological and social innovation, * in order to develop proof-of-concept of a scalable and cost effective personalised digital health program for (pre)obesity patients, * by integrating, in an ethical manner, adaptive AI components aimed at personalisation of the program as well as its cost management, * with the ultimate objective to support sustained behavioural change leading to adoption and internalisation of healthy lifestyle choices.
Eligibility criteria
Qualifiers
obesity (BMI 27-42 kg/m²)
capacity and willingness to use smartphone
capacity and willingness to use wearables
readiness to change (validated questionaire)
Disqualifiers
diseases that prevent participation in the program, or insufficiently controlled diseases, or terminal-stage illnesses
excessive alcohol consumption or a history of other addictions
patients currently participating in a weight-loss program (commercial, medically supervised, or a research study)
patients using anti-obesity medications who are in the dosage adjustment phase within the last four weeks
Trial design
Treatments tested in this trial
- technology driven self coaching
- Health coaching
- Peer coaching
- Active Control
Treatment groups
320 Participants
are divided into 4 treatment groupsSponsors and collaborators
Slovak Academy of Sciences
Lead sponsor
University Hospital Bratislava
Collaborator
Kempelen Institute of Inteligent Technologies
Collaborator
Source ClinicalTrials.gov